158 related articles for article (PubMed ID: 2306831)
21. Divergence between refractoriness of His-Purkinje system and ventricular muscle with abrupt changes in cycle length.
Denker S; Lehmann MH; Mahmud R; Gilbert C; Akhtar M
Circulation; 1983 Dec; 68(6):1212-21. PubMed ID: 6640874
[TBL] [Abstract][Full Text] [Related]
22. Frequency-dependent electrophysiologic effects of amiodarone in humans.
Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
[TBL] [Abstract][Full Text] [Related]
23. Conduction velocity depression and drug-induced ventricular tachyarrhythmias. Effects of lidocaine in the intact canine heart.
Anderson KP; Walker R; Lux RL; Ershler PR; Menlove R; Williams MR; Krall R; Moddrelle D
Circulation; 1990 Mar; 81(3):1024-38. PubMed ID: 2155070
[TBL] [Abstract][Full Text] [Related]
24. Effects of sympathetic stimulation on use dependence of lidocaine, mexiletine, and quinidine in an intact canine model.
Newman D; Herre JM; Chin M; Scheinman MM; Franz M; Katzung B
Can J Physiol Pharmacol; 1992 Feb; 70(2):219-24. PubMed ID: 1325863
[TBL] [Abstract][Full Text] [Related]
25. Effects of quinidine on ventricular repolarization.
Brugada J; Sassine A; Escande D; Masse C; Puech P
Eur Heart J; 1987 Dec; 8(12):1340-5. PubMed ID: 3436332
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of his bundle pacing as an alternative pacing site: measurement of his refractoriness.
Gula LJ; Trim GM; Krahn AD; Skanes AC; Yee R; Klein GJ
J Interv Card Electrophysiol; 2005 Jan; 12(1):69-73. PubMed ID: 15717154
[TBL] [Abstract][Full Text] [Related]
27. Isoproterenol antagonizes drug-induced prolongation of action potential duration in humans.
Newman D; Dorian P; Feder-Elituv R
Can J Physiol Pharmacol; 1993; 71(10-11):755-60. PubMed ID: 8143233
[TBL] [Abstract][Full Text] [Related]
28. Effects of flecainide and quinidine on human atrial action potentials. Role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues.
Wang ZG; Pelletier LC; Talajic M; Nattel S
Circulation; 1990 Jul; 82(1):274-83. PubMed ID: 2114235
[TBL] [Abstract][Full Text] [Related]
29. Discrepant effects of mexiletine on cycle length of ventricular tachycardia and on the effective refractory period in the area of slow conduction.
Aizawa Y; Chinushi M; Kitazawa H; Washizuka T; Abe A; Shibata A; Kodama I
Heart; 1996 Mar; 75(3):281-6. PubMed ID: 8800993
[TBL] [Abstract][Full Text] [Related]
30. Effects of abrupt changes in cycle length on atrial refractory periods in man.
Soni JS; Denker ST; Lehmann MH; Mahmud R; Addas A; Akhtar M
Am Heart J; 1987 Aug; 114(2):315-20. PubMed ID: 3604888
[TBL] [Abstract][Full Text] [Related]
31. The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
Sager PT; Follmer C; Uppal P; Pruitt C; Godfrey R
Circulation; 1994 Oct; 90(4):1811-9. PubMed ID: 7923666
[TBL] [Abstract][Full Text] [Related]
32. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
Roden DM; Iansmith DH; Woosley RL
J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a reexcitability gap in man after treatment with type I antiarrhythmic drugs.
Haberman RJ; Rials SJ; Stohler JL; Marinchak RA; Kowey PR
Am Heart J; 1993 Nov; 126(5):1121-6. PubMed ID: 8237754
[TBL] [Abstract][Full Text] [Related]
34. Direct and autonomically mediated effects of oral quinidine on RR/QT relation after an abrupt increase in heart rate.
Cappato R; Alboni P; Codecà L; Guardigli G; Toselli T; Antonioli GE
J Am Coll Cardiol; 1993 Jul; 22(1):99-105. PubMed ID: 8509572
[TBL] [Abstract][Full Text] [Related]
35. Interactions of ethanol and quinidine on contractility and myocyte action potential in the rat ventricle.
Guthrie SK; Wilde DW; Brown RA; Savage AO; Bleske B
J Electrocardiol; 1995 Jan; 28(1):39-47. PubMed ID: 7897336
[TBL] [Abstract][Full Text] [Related]
36. LV based pacing in patients with heart failure and a narrow QRS--an acute hemodynamic study.
Dwivedi S; Sheth C; Puri A; Narain V; Saran R; Puri V
Indian Heart J; 2007; 59(3):250-5. PubMed ID: 19124935
[TBL] [Abstract][Full Text] [Related]
37. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.
Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ
Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598
[TBL] [Abstract][Full Text] [Related]
38. Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease.
Platia EV; Weisfeldt ML; Franz MR
Am J Cardiol; 1988 Jun; 61(15):1284-7. PubMed ID: 3376887
[TBL] [Abstract][Full Text] [Related]
39. Longer Paced QRS Duration is Associated With Increased Prevalence of Right Ventricular Pacing-Induced Cardiomyopathy.
Khurshid S; Liang JJ; Owens A; Lin D; Schaller R; Epstein AE; Marchlinski FE; Frankel DS
J Cardiovasc Electrophysiol; 2016 Oct; 27(10):1174-1179. PubMed ID: 27457998
[TBL] [Abstract][Full Text] [Related]
40. Electrical restitution and conduction intervals of ventricular premature beats in man: influence of heart rate.
Endresen K; Amlie JP
Pacing Clin Electrophysiol; 1989 Aug; 12(8):1347-54. PubMed ID: 2476758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
